Crossmark

Determination of Tumor Dose Response Thresholds in Patients with Chemorefractory Intrahepatic Cholangiocarcinoma Treated with Resin and Glass-based Y90 Radioembolization

Crossref DOI link: https://doi.org/10.1007/s00270-021-02834-0

Published Online: 2021-04-22

Published Print: 2021-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Cheng, Bernard https://orcid.org/0000-0002-5414-4259
Villalobos, Alex

Sethi, Ila

Wagstaff, William

Galt, James

Brandon, David

Schuster, David M.

Bercu, Zachary

Majdalany, Bill

Kokabi, Nima
License Information

Text and Data Mining valid from 2021-04-22

Version of Record valid from 2021-04-22
More Information

Article History

Received: 22 August 2020

Accepted: 30 March 2021

First Online: 22 April 2021

Declarations

:

: Nima Kokabi conducts research partially funded by Sirtex Medical Ltd. No grant funding has been received for the development of this manuscript. The remaining authors have no financial disclosures.

: For this type of study formal consent is not required.

: This study has obtained approval from our tertiary center’s IRB and the need for informed consent was waived.

: For this type of study consent for publication is not required.

Document is current

Any future updates will be listed below